ViewRay Incorporated

173 articles with ViewRay Incorporated

• ViewRay, GenesisCare and the University of Oxford Announce Groundbreaking Compassionate Access Programme Now Open to UK Patients with Localized Pancreatic Cancer

  8/27/2020

  ViewRay, the GenesisCare Foundation and the Pancreatic Cancer Research Fund Work Together to Provide MRIdian Radiation Therapy at No Cost to NHS Pancreatic Cancer Patients

• Dartmouth-Hitchcock Health Begins Patient Treatments with ViewRay's MRIdian Linac

  8/13/2020

  ViewRay, Inc. announced that Dartmouth-Hitchcock Health in New Hampshire has begun patient treatments with the MRIdian® MRI-Guided Therapy System, a cutting-edge radiation therapy device that combines the latest innovations in precision radiation delivery and ground-breaking MR-guidance.

• Kaohsiung Medical University Chung-Ho Memorial Hospital Begins Patient Treatments with ViewRay's MRIdian Linac

  8/5/2020

  ViewRay, Inc. announced that Kaohsiung Medical University Chung-Ho Memorial Hospital in Kaohsiung City, Taiwan has begun patient treatments with the MRIdian® MR-Guided Radiation Therapy System, a cutting-edge device that delivers personalized cancer care by combining the latest innovations in precision radiation delivery with ground-breaking MR-guidance.

• ViewRay Reports Second Quarter 2020 Results

  7/30/2020

  ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the second quarter ended June 30, 2020 . Second Quarter 2020 Highlights: Total revenue of $14.2 million , primarily from two reve

• ViewRay Announces Conference Call for Second Quarter 2020 Financial Results to be Held After Market on July 30, 2020

  7/13/2020

  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its second quarter 2020 financial results. ViewRay will hold a conference call to discuss results on Thursday, July 30, 20

• ViewRay Announces 1-Year Outcomes on MR-Guided Radiation Treatment for Prostate Cancer Without Implanted Markers

  6/23/2020

  Study Shows Low Incidence of Toxicity Using Stereotactic Body Radiation Therapy (SBRT) While Reducing Potential Complications Associated with Implanted Markers

• ViewRay Announces Equity Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - June 04, 2020

  6/4/2020

  ViewRay, Inc. announced grants of stock options and restricted stock units to Zach Stassen, Chief Financial Officer for the company.

• ViewRay® to Present at the Jefferies 2020 Virtual Healthcare Conference

  5/28/2020

  ViewRay, Inc. announced that the Company will present at the Jefferies 2020 Virtual Healthcare Conference.

• Providence Portland Medical Center Begins Patient Treatments with ViewRay's MRIdian Linac

  5/27/2020

  ViewRay, Inc. announced that Providence Portland Medical Center in Portland, Oregon has begun patient treatments with the MRIdian® MR-Guided Therapy System, a cutting-edge radiation therapy system that combines the latest innovations in precision radiation delivery and ground-breaking MR-guidance.

• ViewRay Reports First Quarter 2020 Results

  4/30/2020

  ViewRay, Inc. announced financial results for the first quarter ended March 31, 2020..

• ViewRay Names Zach Stassen as Chief Financial Officer

  4/30/2020

  ViewRay, Inc. (Nasdaq: VRAY) announced today that Zach Stassen has been named Chief Financial Officer, effective May 18, 2020.

• ViewRay Announces Appointment of B. Kristine Johnson to its Board of Directors

  4/16/2020

  ViewRay, Inc. (Nasdaq: VRAY) announced the appointment of B. Kristine Johnson to its Board of Directors effective April 14, 2020.

• ViewRay Announces Conference Call for First Quarter 2020 Financial Results to be Held After Market on April 30, 2020

  4/9/2020

  ViewRay, Inc. announced details relating to the release of its first quarter 2020 financial results..

• ViewRay and VieCure Announce Strategic Collaboration to Accelerate Adoption of Personalized Cancer Care

  4/1/2020

  Collaboration offers clinicians a personalized oncology solution that combines cutting-edge MRI-guided radiation therapy with a leading AI-driven EMR integration platform

• Enloe Medical Center Becomes First Community Hospital in Northern California to Purchase a MRIdian MRI-Guided Radiation Therapy System

  3/19/2020

  System Order Will Bring the Benefits of MRI-guidance and On-table Adaptive Therapy to Patients Throughout the Region

• Ludwig-Maximilians-University Hospital Begins Patient Treatments with ViewRay's MRIdian Linac

  3/18/2020

  First Treatments at Munich Hospital Leverage MRIdian's Precision for High-Dose Delivery and Adaptive Therapy Capabilities

• ViewRay Reports Fourth Quarter and Full Year 2019 Results

  3/12/2020

  ViewRay, Inc. announced financial results for the fourth quarter and full year ended December 31, 2019.

• ViewRay Announces Conference Call and Webcast of Fourth Quarter and Full Year 2019 Financial Results to be Held After Market on March 12, 2020

  2/13/2020

  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its fourth quarter and full year 2019 financial results.

• ViewRay Announces Preliminary Fourth Quarter and Full Year 2019 Results

  1/13/2020

  ViewRay, Inc. announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2019. The preliminary results have not been audited and are subject to change.

• Michigan Community Hospital Begins Patient Treatments with ViewRay's MRIdian Linac

  12/19/2019

  Sparrow Health System Now Delivering On-Table Adaptive Therapy with New MRI-Guided Radiation Therapy System